Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center

Conclusions: Inhaled dornase alfa is commonly prescribed to improve atelectasis and secretions in a non-cystic fibrosis patient population at a tertiary academic medical center.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Tags: Research Articles Source Type: research